AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

AB Glymprd M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview AB Glymprd M 1mg/500mg Tablet SR

Glymard-M 1mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Glymard-M should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and know how to counteract them with readily available glucose sources like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is a possible consequence. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Glymard-M should be used cautiously during pregnancy and breastfeeding, requiring prior medical consultation. Regular blood glucose monitoring is necessary; your doctor might order blood tests to assess blood cell counts and liver function.

Uses of AB Glymprd M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of AB Glymprd M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The AB Glymprd M 1mg/500mg Sustained-Release tablet should be administered with a meal.

Common Side effects of AB Glymprd M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use AB Glymprd M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. AB Glymprd M 1mg/500mg Extended-Release tablets should be taken with a meal.

How AB Glymprd M 1mg/500mg Tablet SR works:

AB Glymprd M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with AB Glymprd M 1mg/500mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release AB Glymprd M 1mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

The extended-release combination tablet, AB Glymprd M 1mg/500mg, is contraindicated during lactation due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering AB Glymprd M 1mg/500mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. The use of AB Glymprd M 1mg/500mg SR tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

The extended-release combination tablet, AB Glymprd M 1mg/500mg, requires careful administration in individuals with hepatic impairment. Dosage modification of AB Glymprd M 1mg/500mg may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiation of AB Glymprd M 1mg/500mg should begin with a reduced dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take AB Glymprd M 1mg/500mg Tablet SR :

Should you forget to take a scheduled AB Glymprd M 1mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About AB Glymprd M 1mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on AB Glymprd M 1mg/500mg Tablet SR

Store the medication in its original, tightly sealed container or packaging. Follow the storage guidelines printed on the label or packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Indeed, AB Glymprd M 1mg/500mg Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent but potentially dangerous adverse reaction linked to metformin use. Consequently, its use is cautioned against in individuals with pre-existing kidney problems, the elderly, and heavy alcohol consumers. Manifestations of lactic acidosis can encompass muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, queasiness, emesis, abdominal pain, and bradycardia. Should these symptoms arise, discontinue AB Glymprd M 1mg/500mg Tablet SR and seek immediate medical attention.
The extended-release tablet AB Glymprd M (1 mg glimepiride/500 mg metformin) combines two diabetes medications. This formulation treats type 2 diabetes mellitus by improving blood sugar control in adults when used with a suitable diet and exercise program. Glimepiride's action reduces blood glucose by stimulating pancreatic insulin secretion. Metformin lowers hepatic glucose production and enhances insulin responsiveness. This dual-agent therapy is unsuitable for type 1 diabetes management.
Taking AB Glymprd M 1mg/500mg SR tablets may cause common side effects such as low blood sugar, changes in taste perception, nausea, abdominal discomfort, loose stools, and headaches. Rare but potentially serious side effects include lactic acidosis. Prolonged use might result in vitamin B12 deficiency.
Prolonged use of AB Glymprd M 1mg/500mg Tablet SR may lead to Vitamin B12 deficiency due to impaired intestinal absorption of the vitamin. This deficiency, if left unaddressed, can result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and gait instability. Preventive strategies proposed by some studies include supplemental Vitamin B12 at least annually.
Indeed, AB Glymprd M 1mg/500mg sustained-release tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This adverse effect is amplified by skipped meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carry a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, at all times.
Consuming alcohol concurrently with AB Glymprd M 1mg/500mg Tablet SR is inadvisable due to the risk of dangerously low blood sugar (hypoglycemia). Furthermore, this combination may heighten the likelihood of lactic acidosis.
AB Glymprd M 1mg/500mg Ta...
102
MRP 124
17% off